UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 29, 2004

 

EPIX Medical, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-21863

 

04-3030815

(State or other
jurisdiction of
incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

 

 

 

 

71 Rogers Street
Cambridge, Massachusetts 02142

(Address of principal executive offices) (Zip Code)

 

 

 

 

 

Registrant’s telephone number, including area code: (617) 250-6000

 

 

 

Item 7.  Financial Statements and Exhibits.

 

(c) The following exhibits are furnished with this report:

 

Exhibit Number

 

Description

 

 

 

99.1

 

Press Release dated April 29, 2004.

 

Item 9.  Regulation FD Disclosure.

 

The following information is furnished pursuant to Item 12, “Disclosure of Results of Operations and Financial Conditions.”

 

On April 29, 2004, the Registrant issued a press release to report its financial results for the first quarter ended March 31, 2004.  A copy of the press release is attached to this current report on Form 8-K as Exhibit 99.1.

 

In accordance with the procedural guidance in SEC Release No. 33-8216, the information in this Form 8-K and the Exhibit attached to this Form 8-K are being furnished under “Item 9. Regulation FD Disclosure” rather than under “Item 12. Disclosure of Results of Operations and Financial Condition.”  The information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 
EPIX Medical, Inc.
 

(Registrant)

 

 

 

 

Date: April 29, 2004

/s/ Peyton J. Marshall

 

 

Peyton J. Marshall

 

Senior Vice-President,

 

Finance and Administration,

 

Chief Financial Officer

 

3